![]() |
市場調查報告書
商品編碼
2032664
粘合劑和輔料市場報告:按產品類型、應用和地區分類(2026-2034 年)Binder Excipients Market Report by Product Type (Cellulosics, Lactose, Polyols, Povidones, Starch and Polysaccharides, Co-Processed Compressible Excipients, and Others), Application (Tablets and Capsules, Solution Based), and Region 2026-2034 |
||||||
2025年,全球粘合劑和輔料市場規模達16億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到23億美元,2026年至2034年的複合年成長率為3.77%。公眾對口服藥物需求的不斷成長、對以患者為中心的製劑日益關注以及廣泛的研發活動是推動市場成長的主要因素。
粘合劑是藥物製劑的重要組成部分,尤其是在固態口服製劑中。它們用於將活性成分和其他成分粘合在片劑和膠囊中,從而形成穩定且易於操作的最終產品。這些分子具有親水性,能夠與其他製劑成分(例如纖維素衍生物)形成強烈的分子間相互作用。粘合劑的主要作用之一是提高粉末混合物的可壓縮性,使片劑和膠囊具有盡可能均勻的尺寸和形狀,確保劑量的一致性和可預測性。此外,它們還有助於改善粉末混合物的流動性,以便於片劑壓片和膠囊填充。它們還有助於控制活性成分的釋放。控制釋放是粘合劑輔料的另一個重要功能,有助於維持藥物的治療效果。這對於治療範圍有限或僅在體內特定部位吸收的藥物至關重要。粘合劑輔料有多種類型,包括天然和合成聚合物、醣類和澱粉。
患者對口服藥物需求的不斷成長是全球市場的主要驅動力。這主要歸功於口服藥物的許多優勢,例如給藥方便、便利性以及劑量精準,這些優勢推動了市場發展。此外,許多製藥公司正大力投資研發新型片劑和膠囊製劑,從而提升了對粘合劑和輔料的需求。同時,以患者為中心的製劑研發日益受到重視,旨在提高患者的用藥依從性和治療方案的執行力,這也為市場提供了強力的支撐。因此,新型藥物遞送系統(例如緩釋片和膠囊)的研發,需要使用特殊的粘合劑和輔料,這也促進了市場需求。此外,營養保健品(即提供健康益處的營養補充劑)需求的成長也對市場產生了積極影響。品牌藥專利到期導致學名藥需求增加,也推動了市場成長。同時,新型輔料(例如共加工輔料)的研發也提振了市場前景。推動市場發展的其他因素包括對創新治療方法的需求不斷成長以及醫療保健行業的持續改進。
The global binder excipients market size reached USD 1.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.77% during 2026-2034. The increasing demand for oral medications among the masses, the growing focus on patient-centric formulations, and extensive research and development activities represent some of the key factors driving the market.
Binder excipients act as one of the essential components in pharmaceutical formulations, especially when utilized in solid oral dose forms. They are employed to bind the pharmaceutical active substances and other elements of a tablet or capsule, resulting in a stable and manageable final product. They are hydrophilic molecules that can generate potent intermolecular interactions with the other components of the formulation, such as cellulose derivatives. Enhancing the powder mixture's compressibility is one of the primary purposes of binder excipients, which provide tablets or capsules with the constant size and shape possible, guaranteeing a consistent and predictable dose. Additionally, they aid in enhancing the powder mixture's flow characteristics, making it simpler to compress tablets or fill capsules. They also aid in controlling the release of the active ingredient release is another crucial function of binder excipients as well as they help in maintaining the therapeutical effect of the medicinal drugs, which is crucial for medications to have a limited therapeutic window or are absorbed only in certain parts of the body. There are several types of binder excipients available, including natural and synthetic polymers, sugars, and starches.
The escalating demand for oral medicines among the patients majorly drives the global market. This is due to their several benefits, such as easy administration, convenience, and accurate dosing, which are driving the market. In addition, numerous pharmaceutical companies are investing heavily in the development of new tablet and capsule formulations, which is propelling the demand for binder excipients. Along with this, the growing focus on patient-centric formulations, which are created to improve patient compliance and adherence to a medication regimen, is significantly supporting the market. In line with this, the development of novel drug delivery systems, such as modified-release tablets and capsules, requiring specialized binder excipients is also providing a thrust to the demand. Apart from this, the growing demand for nutraceuticals, which are dietary supplements that offer health benefits, is influencing the market favorably. In addition, the rising demand for generic drugs on account of the increasing number of patents expiring on branded drugs is contributing to the market. Furthermore, the development of novel excipients, such as co-processed excipients, is creating a positive market outlook. Some of the other factors driving the market include the rising demand for innovative therapies and continual improvements in the healthcare sector.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. According to the report, North America was the largest market for binder excipients. Some of the factors driving the North America binder excipients market included technological advancements, increasing investments in innovations, and significant growth in the pharmaceutical industry across the region.
The report has also provided a comprehensive analysis of the competitive landscape in the global binder excipients market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered are Colorcon, Croda International, EMD Millipore, Dow Chemical, FMC BioPolymer, Fuji Chemical Industry and Ingredion. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.